Impacts of autophagy-inducing ingredient of areca nut on tumor cells

Ching-Yu Yen1, Wei-Fan Chiang2, Shyun-Yeu Liu1

  • 1Department of Dentistry, Taipei Medical University, Taipei, Taiwan; Department of Dentistry, National Defense Medical Center, Taipei, Taiwan; Oral and Maxillofacial Surgery Section, Chi Mei Medical Center, Tainan, Taiwan.

Plos One
|May 29, 2015
PubMed

Insights

Areca nut extract induces autophagic cell death through Beclin-1 and Atg5, with the MEK/ERK pathway involved. Long-term exposure may enhance tumor cell resistance to serum deprivation.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Autophagy Research

Background:

  • Areca nut (AN) is a widespread carcinogen linked to various cancers.
  • Previous studies showed AN extract (ANE) and its fraction (ANE 30-100K) induce autophagic cell death.
  • The precise molecular mechanisms of ANE-induced autophagy require further elucidation.

Purpose of the Study:

  • To investigate the detailed molecular mechanisms of ANE 30-100K-induced autophagy (AIA).
  • To explore the roles of AMP-activated protein kinase (AMPK), Beclin-1, Atg5, and the MEK/ERK pathway in AIA.
  • To assess the impact of long-term ANE 30-100K exposure on cancer cell resistance.

Main Methods:

  • Utilized chemical inhibitors and small hairpin RNA (shRNA) for gene knockdown (AMPK, Atg5, Beclin 1).
  • Examined AIA in various cancer cell lines (Jurkat T, OECM-1, CE81T/VGH, SCC25, SCC-15) and multiple myeloma/lymphoma cells.
  • Assessed caspase-3 activation and MEK/ERK pathway involvement.
  • Investigated cell resistance to serum deprivation after long-term ANE 30-100K treatment.

Main Results:

  • AMPK inhibition attenuated AIA in Jurkat T cells but not OECM-1 cells.
  • Knockdown of Atg5 and Beclin 1 significantly ameliorated AIA in tested cell lines.
  • ANE 30-100K activated caspase-3 upon Beclin 1 inhibition in specific cancer cells.
  • The MEK/ERK pathway was identified as an upstream activator of AIA in Jurkat T cells and involved in other cell lines.
  • Long-term ANE 30-100K treatment enhanced autophagy-mediated resistance to serum deprivation in surviving tumor cells.

Conclusions:

  • Beclin-1 and Atg5 are commonly required for AIA, while AMPK's role is cell-type specific.
  • The MEK/ERK signaling pathway plays a significant role in AIA.
  • Prolonged exposure to Areca nut extract may confer resistance to nutrient-deprived conditions in tumor cells, potentially impacting therapeutic outcomes.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
5.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.6K